Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone Therapy With or Without Radiotherapy in Metastatic Prostate Cancer
NCT02913859Phase 2Unknown
- Sponsor
- University Hospital Center Sestre milosrdnice
- Start
- Sep 2018
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by University Hospital Center Sestre milosrdnice. Primary endpoint: Disease Progression-Free Survival at 4 years. Status: unknown.
Beyond the preview
Go deeper on NCT02913859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02913859.